937 related articles for article (PubMed ID: 6139800)
21. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
Frisk-Holmberg M; Juhlin-Dannfelt A; Aström H
Clin Physiol; 1985 Jun; 5(3):231-42. PubMed ID: 2860992
[TBL] [Abstract][Full Text] [Related]
22. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
Snedden W; Fernandez PG; Vasdev S; Bolli P
Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
[TBL] [Abstract][Full Text] [Related]
24. Mild high-renin essential hypertension. Neurogenic human hypertension?
Esler M; Julius S; Zweifler A; Randall O; Harburg E; Gardiner H; DeQuattro V
N Engl J Med; 1977 Feb; 296(8):405-11. PubMed ID: 834210
[TBL] [Abstract][Full Text] [Related]
25. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
[TBL] [Abstract][Full Text] [Related]
26. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension.
Jacobs MC; Lenders JW; Willemsen JJ; Thien T
J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663
[TBL] [Abstract][Full Text] [Related]
27. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
van Baak MA; Böhm RO; Arends BG; van Hooff ME; Rahn KH
Int J Sports Med; 1987 Oct; 8(5):342-7. PubMed ID: 2890591
[TBL] [Abstract][Full Text] [Related]
28. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
Koebe P; Rost R; Reinke A; Nagel N; Merten U
Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
[TBL] [Abstract][Full Text] [Related]
29. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
[TBL] [Abstract][Full Text] [Related]
30. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
32. [Exercise hemodynamics and renin before and after acute beta block in patients with essential hypertension].
Burkart F; Bühler FR; Pfisterer M; Küng M
Schweiz Med Wochenschr; 1976 Dec; 106(49):1732-5. PubMed ID: 13488
[TBL] [Abstract][Full Text] [Related]
33. Beta blockers with intrinsic sympathomimetic activity.
White WB
Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
[TBL] [Abstract][Full Text] [Related]
34. [Comparative effects of seven beta adrenolytic agents on blood pressure after injection into the posterior hypothalamus of rats. The frequency heart and the plasma renin activity (author's transl)].
Bentue-Ferrer D; Allain H; Van den Driessche J; Pape D; Reymann JM
J Pharmacol; 1981; 12(2):161-77. PubMed ID: 6115097
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic effects of nifedipine in hypertension in the presence of elevated angiotensin-II and beta-adrenergic blockade.
Blau A; Battler A; Eldar M; Rath S; Neufeld HN; Kapuler S; Iaina A; Cohen D; Eliahou HE
J Clin Hypertens; 1986 Mar; 2(1):13-20. PubMed ID: 2873210
[TBL] [Abstract][Full Text] [Related]
36. The beta-adrenoceptor controlling renin release.
Oates HF; Stoker LM; Monaghan JC; Stokes GS
Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):205-13. PubMed ID: 213037
[TBL] [Abstract][Full Text] [Related]
37. Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.
Colfer HT; Cottier C; Sanchez R; Julius S
Hypertension; 1984; 6(2 Pt 1):145-51. PubMed ID: 6144632
[TBL] [Abstract][Full Text] [Related]
38. Beta-blockers in hypertension.
Hansson L
J Hypertens Suppl; 1987 Aug; 5(3):S61-7. PubMed ID: 2889813
[TBL] [Abstract][Full Text] [Related]
39. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
[TBL] [Abstract][Full Text] [Related]
40. Clinical studies with captopril treatment of hypertensive patients.
Varga K; Alföldi S; Kiss I; Simkó K; Farsang C
Acta Physiol Hung; 1988; 72 Suppl():67-78. PubMed ID: 2855293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
